Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (51-60 of 442) with videos related to

Pageof 45
Sort By:
Cancer|March 23, 2017
Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Dietrich Beelen, et al.
Journal of Hematology & Oncology|February 14, 2023
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMTFrédéric Baron, Myriam Labopin, Johanna Tischer, et al.
British Journal of Haematology|February 23, 2018
Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow TransplantationYishai Ofran, Eric Beohou, Myriam Labopin, et al.
Haematologica|September 9, 2017
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationCatherine J Lee, Bipin N Savani, Mohamad Mohty, et al.
Bone Marrow Transplantation|August 9, 2018
Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysisVipul Sheth, Myriam Labopin, Jonathan Canaani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemiaOlle Ringdén, Myriam Labopin, Gerhard Ehninger, et al.
Blood|April 17, 2010
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemiaSebastian Giebel, Myriam Labopin, Gerhard Ehninger, et al.
American Journal of Hematology|September 28, 2016
Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia-A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSandra Eder, Eric Beohou, Myriam Labopin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationOlle Ringdén, Myriam Labopin, Norbert-Claude Gorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remissionNorbert-Claude Gorin, Myriam Labopin, Didier Blaise, et al.
Pageof 45

Showing results (51-60 of 442) with videos related to

Sort By:
Pageof 45
Cancer|March 23, 2017
Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Dietrich Beelen, et al.
Journal of Hematology & Oncology|February 14, 2023
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMTFrédéric Baron, Myriam Labopin, Johanna Tischer, et al.
British Journal of Haematology|February 23, 2018
Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow TransplantationYishai Ofran, Eric Beohou, Myriam Labopin, et al.
Haematologica|September 9, 2017
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationCatherine J Lee, Bipin N Savani, Mohamad Mohty, et al.
Bone Marrow Transplantation|August 9, 2018
Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysisVipul Sheth, Myriam Labopin, Jonathan Canaani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemiaOlle Ringdén, Myriam Labopin, Gerhard Ehninger, et al.
Blood|April 17, 2010
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemiaSebastian Giebel, Myriam Labopin, Gerhard Ehninger, et al.
American Journal of Hematology|September 28, 2016
Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia-A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSandra Eder, Eric Beohou, Myriam Labopin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationOlle Ringdén, Myriam Labopin, Norbert-Claude Gorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remissionNorbert-Claude Gorin, Myriam Labopin, Didier Blaise, et al.
Pageof 45